NVCT - Nuvectis Pharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.9 0.17 (2.88%) --- 0.0 (0.0%) 0.06 (1.0%) --- 0.17 (2.88%) --- ---

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.3
Diluted EPS:
-0.3
Basic P/E:
-20.2333
Diluted P/E:
-20.2333
RSI(14) 1m:
100.0
VWAP:
6.07
RVol:

Events

Period Kind Movement Occurred At

Related News